Delivery Order SPE2DB20D1004-SPE2DB25FNHEA
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 mL pens valued at $1,501.50, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 mL pens valued at $1,334.04. The contract employs firm fixed pricing with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025, without set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $10,268.84 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 16, 2026, for Trulicity 0.75 mg/0.5 mL pens. The award, which carries an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 15, 2026, for the supply of Trulicity 4.5 mg/0.5 mL pens in 0.5 mL dosages. This firm fixed-price delivery order, valued at $1,898.88, is scheduled for completion by January 16, 2026, and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on September 16, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 mL pens in 0.5 mL doses. The contract is valued at $27,736.02 with a completion date of September 17, 2025 and operates under a firm fixed-price delivery order model. This award is not designated as a set-aside contract and represents a competitive award issued under...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNHEADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pen medication with a ceiling value of $1,121.31. The contract was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, and utilizes firm fixed price terms. This delivery order represents a non-set-aside, competitively awarded transaction and is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's comprehensive pharmaceutical supply support to military healthcare systems worldwide. The delivery order falls within AmerisourceBergen's established pharmaceutical distribution role supporting federal medical procurement needs for the Department of Defense and related healthcare entities. Trulicity is a diabetes medication within the company's portfolio of brand-name and generic pharmaceuticals supplied through the DLA Medical Supply Chain. As a child contract under the larger SPE2DX indefinite delivery vehicle, this order exemplifies the ongoing supply of critical pharmaceutical commodities to military personnel and veterans through the company's established federal contracting relationships with the DLA Troop Support Medical division.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/20/25 |